Keros Therapeutics, Inc. short interest in 2025
In 2025, Keros Therapeutics, Inc.'s disclosed short interest ran from 9.92% of shares outstanding on 15 Jan 2025 to 8.15% on 31 Dec 2025, a change of -1.77 percentage points. The year's high was 22.26% on 14 Nov 2025 and its low 8.15% on 31 Dec 2025, averaging 11.79% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.36 days on 15 Sep 2025. Full history: Keros Therapeutics, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 9.92% (15 Jan 2025)
- End of year
- 8.15% (31 Dec 2025)
- Change
- -1.77 pp
- High
- 22.26% (14 Nov 2025)
- Low
- 8.15% (31 Dec 2025)
- Average
- 11.79%
- Highest days to cover
- 14.36 (15 Sep 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 9.92% | 1.65 | |
| 31 Jan 2025 | 10.51% | 2.34 | |
| 14 Feb 2025 | 10.20% | 3.93 | |
| 28 Feb 2025 | 10.33% | 3.86 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 9.92% | 4.98 | |
| 31 Mar 2025 | 10.01% | 6.10 | |
| 15 Apr 2025 | 10.88% | 2.38 | |
| 30 Apr 2025 | 13.00% | 4.80 | |
| 15 May 2025 | 14.21% | 6.97 | 10-Q filed, results (8-K) |
| 30 May 2025 | 13.06% | 9.20 | |
| 13 Jun 2025 | 11.58% | 6.21 | |
| 30 Jun 2025 | 12.72% | 10.28 | |
| 15 Jul 2025 | 12.43% | 11.54 | |
| 31 Jul 2025 | 11.92% | 10.69 | |
| 15 Aug 2025 | 11.90% | 11.16 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 11.08% | 8.28 | |
| 15 Sep 2025 | 11.37% | 14.36 | |
| 30 Sep 2025 | 9.52% | 11.98 | |
| 15 Oct 2025 | 9.40% | 3.81 | results (8-K) |
| 31 Oct 2025 | 19.24% | 5.41 | |
| 14 Nov 2025 | 22.26% | 5.39 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 10.60% | 2.40 | |
| 15 Dec 2025 | 8.84% | 3.04 | |
| 31 Dec 2025 | 8.15% | 4.58 |
See also: Keros Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.